SCHEMBL8779088

SCHEMBL8779088

C=C1c2cc(F)ccc2CCC12CCCC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.39
PARP10 Q53GL7 1/20 0.39
KDM1A O60341 2/20 0.38
SRD5A1 P18405 1/20 0.38
ACHE P22303 1/20 0.33
NPY5R Q15761 2/20 0.32
HTR5A P47898 2/20 0.32
DRD2 P14416 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR2B P41595 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
TYMS P04818 2/20 0.31
HDAC4 P56524 2/20 0.31
PSEN1 P49768 1/20 0.30
PSEN2 P49810 1/20 0.30
APH1B Q8WW43 1/20 0.30
NCSTN Q92542 1/20 0.30
APH1A Q96BI3 1/20 0.30
PSENEN Q9NZ42 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8778992 0.80 TDP1 (0.39) PARP1PARP10KDM1ASIGMAR1TYMS
SCHEMBL8779056 0.80 F7 (0.39) PARP1PARP10KDM1ASRD5A1ACHE
SCHEMBL8779123 0.80 TDP2 (0.36) TYMS
SCHEMBL8779154 0.80 PARP1 (0.46) PARP1PARP10KDM1ASRD5A1ACHE
SCHEMBL8779005 0.80 MAPT (0.33) TYMS
SCHEMBL8778942 0.76 METAP1 (0.44) KDM1AHTR5AHTR2CHTR2BSIGMAR1
SCHEMBL8778991 0.75 SIGMAR1 (0.44) DRD2HTR2AHTR2CHTR2BSIGMAR1
SCHEMBL8778969 0.72 KDM1A (0.34) KDM1A
SCHEMBL20423549 0.72 SIGMAR1 (0.44) DRD2HTR2AHTR2CHTR2BSIGMAR1
SCHEMBL8779058 0.70 METAP1 (0.40) KDM1ASRD5A1ACHEDRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606661-B1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists HOFFMANN LA ROCHE (CH) 1997-03-12 EP disclosed
US-5385947-A For prevention of nerve damage due to reduction of blood or oxygen supplies HOFFMANN-LA ROCHE INC. (US) 1995-01-31 US disclosed
EP-0606661-A1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists F. HOFFMANN-LA ROCHE AG (CH) 1994-07-20 EP disclosed